These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7008557)

  • 1. Dermal copper drugs: the copper bracelet and cu(II) salicylate complexes.
    Walker WR; Beveridge SJ; Whitehouse MW
    Agents Actions Suppl; 1981; 8():359-67. PubMed ID: 7008557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the therapeutic value of the 'copper bracelet'-dermal assimilation of copper in arthritic/rheumatoid conditions.
    Walker WR; Keats DM
    Agents Actions; 1976 Jul; 6(4):454-9. PubMed ID: 961545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ternary copper (II) complexes containing salicylate and nitrogenous chelates such as histamine.
    Walker WR; Reeves R
    Agents Actions Suppl; 1977; (1):109-17. PubMed ID: 272824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper salicylate as an anti-inflammatory and analgesic agent in arthritic rats.
    Jacka T; Bernard CC; Singer G
    Life Sci; 1983 Feb; 32(9):1023-30. PubMed ID: 6600809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution of 64Cu in rats after topical application of two lipophilic anti-inflammatory Cu(II) formulations.
    Beveridge SJ; Boettcher B; Walker WR; Whitehouse MW
    Agents Actions; 1984 Feb; 14(2):291-5. PubMed ID: 6711390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilic copper(II) formulations: some correlations between their composition and anti-inflammatory/anti-arthritic activity when applied to the skin of rats.
    Beveridge SJ; Whitehouse MW; Walker WR
    Agents Actions; 1982 Apr; 12(1-2):225-31. PubMed ID: 7080960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "copper bracelet" for arthritis.
    Whitehouse MW; Walker WR
    Med J Aust; 1977 Jun; 1(25):938. PubMed ID: 887030
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-inflammatory activity of a dermally applied copper salicylate preparation (Alcusal).
    Walker WR; Beveridge SJ; Whitehouse MW
    Agents Actions; 1980 Apr; 10(1 Pt 2):38-47. PubMed ID: 7386307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory activity of copper salicylates applied to rats percutaneously in dimethyl sulphoxide with glycerol.
    Beveridge SJ; Walker WR; Whitehouse MW
    J Pharm Pharmacol; 1980 Jun; 32(6):425-7. PubMed ID: 6106677
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylate.
    Sorenson JR; Hangarter W
    Inflammation; 1977 Sep; 2(3):217-38. PubMed ID: 367963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Copper salicylate in rheumatoid arthritis and rheumatism--like degenerative diseases].
    Hangarter W
    Med Welt; 1980 Nov; 31(45):1625-8. PubMed ID: 6969838
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of triethanolamine salicylate release from the dermatological bases and the commercial products.
    Babar A; Chickhale PJ; Plakogiannis FM
    Pharm Acta Helv; 1991; 66(12):322-8. PubMed ID: 1784579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper salicylate compounds.
    Walker WR
    Med J Aust; 1987 Jul; 147(2):104-6. PubMed ID: 3600451
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiexsudative activity of (methylsalicylate)copper-water compounds].
    Sokolík J; Tumová I; Blahová M; Cellárová M; Svajlenová O; Svec P
    Ceska Slov Farm; 1995 Aug; 44(4):212-4. PubMed ID: 7663874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of the analgesic effect of magnesium salicylate.
    Stern SB
    Med Times; 1967 Oct; 95(10):1072-6. PubMed ID: 4866037
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats.
    Megwa SA; Benson HA; Roberts MS
    J Pharm Pharmacol; 1995 Nov; 47(11):891-6. PubMed ID: 8708981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetranuclear copper(II) complexes bridged by alpha-D-glucose-1-phosphate and incorporation of sugar acids through the Cu4 core structural changes.
    Kato M; Sah AK; Tanase T; Mikuriya M
    Inorg Chem; 2006 Aug; 45(17):6646-60. PubMed ID: 16903719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential dangers from topical preparations containing methyl salicylate.
    Chan TY
    Hum Exp Toxicol; 1996 Sep; 15(9):747-50. PubMed ID: 8880210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper(II) complexes of tridentate pyridylmethylethylenediamines: role of ligand steric hindrance on DNA binding and cleavage.
    Raja A; Rajendiran V; Uma Maheswari P; Balamurugan R; Kilner CA; Halcrow MA; Palaniandavar M
    J Inorg Biochem; 2005 Aug; 99(8):1717-32. PubMed ID: 16039720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.